IMGN logo

ImmunoGen (IMGN) Operating Expenses

Annual Operating Expenses

$329.50 M
+$134.57 M+69.04%

December 31, 2022

Summary

Performance

1-Year Change

+69.04%

3-Year Change

+115.34%

5-Year Change

+89.75%

15-Year Change

+89.75%

IMGN Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$329.50 M
IMGN annual total operating expenses is currently at an all-time high

3-Year Low

$194.93 M
IMGN annual total operating expenses is currently +69.04% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
IMGN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
IMGN next annual earnings announcement has not yet been scheduled

OtherIMGNexpensesmetrics:

Annual Total Expenses

$329.68 M
IMGN annual total expenses is $329.68 million

Annual Interest Expense

$4.17 M
IMGN annual interest expense is $4.17 million

Annual Income Tax

$1.22 M
IMGN annual income tax is $1.22 million

Annual Cost Of Goods Sold

$176.00 K
IMGN annual cost of goods sold is $176.00 thousand

Quarterly Operating Expenses

$85.31 M
-$1.12 M-1.29%

September 30, 2023

Summary

Performance

3-Month Change

-1.29%

1-Year Change

-8.07%

3-Year Change

+144.34%

5-Year Change

+53.47%

IMGN Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$100.55 M
IMGN quarterly total operating expenses is currently -15.15% below its historical high of $100.55 million

3-Year Low

$60.93 M
IMGN quarterly total operating expenses is currently +40.02% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

OtherIMGNexpensesmetrics:

Quarterly Total Expenses

$87.47 M
IMGN quarterly total expenses is $87.47 million

Quarterly Interest Expense

$3.59 M
IMGN quarterly interest expense is $3.59 million

Quarterly Income Tax

-$1.17 M
IMGN quarterly income tax is -$1.17 million

Quarterly Cost Of Goods Sold

$2.15 M
IMGN quarterly cost of goods sold is $2.15 million

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

Annual Operating Expenses

$329.50 M
IMGN annual total operating expenses is $329.50 million

Annual SGA

$116.13 M
IMGN annual SGA is $116.13 million

Annual D&A

$1.78 M
IMGN annual depreciation & amortization is $1.78 million

IMGN Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+69.0%-8.1%
3 y3 years+115.3%+144.3%
5 y5 years+89.8%+53.5%

IMGN Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high-40.8%-15.2%-28.6%
5 y5-yearat high-53.6%-15.2%-61.7%
alltimeall timeat high-99.6%-15.2%-114.1%

ImmunoGen Operating Expenses History

DateAnnualQuarterly
Sep 2023
-
$85.31 M(-1.3%)
Jun 2023
-
$86.43 M(-5.7%)
Mar 2023
-
$91.64 M(-8.9%)
Dec 2022
$329.50 M(+69.0%)
$100.55 M(+8.3%)
Sep 2022
-
$92.80 M(+23.4%)
Jun 2022
-
$75.22 M(+23.4%)
Mar 2022
-
$60.93 M(-2.6%)
Dec 2021
$194.93 M(+27.2%)
$62.55 M(+44.0%)
Sep 2021
-
$43.44 M(-2.0%)
Jun 2021
-
$44.32 M(-0.7%)
Mar 2021
-
$44.62 M(-9.5%)
Dec 2020
$153.19 M(+0.1%)
$49.32 M(+41.2%)
Sep 2020
-
$34.92 M(+6.8%)
Jun 2020
-
$32.69 M(-9.9%)
Mar 2020
-
$36.27 M(+1.2%)
Dec 2019
$153.01 M(-27.6%)
$35.86 M(+18.6%)
Sep 2019
-
$30.22 M(-18.9%)
Jun 2019
-
$37.26 M(-25.0%)
Mar 2019
-
$49.67 M(-7.0%)
Dec 2018
$211.20 M(+21.6%)
$53.43 M(-3.9%)
Sep 2018
-
$55.59 M(+17.4%)
Jun 2018
-
$47.35 M(-13.6%)
Mar 2018
-
$54.83 M(+12.1%)
Dec 2017
$173.65 M(+105.4%)
$48.89 M(+23.5%)
Sep 2017
-
$39.60 M(-10.3%)
Jun 2017
-
$44.16 M(+7.7%)
Mar 2017
-
$41.01 M(-3.2%)
Dec 2016
$84.56 M(-54.3%)
-
Sep 2016
-
$42.37 M(-11.6%)
Jun 2016
$184.99 M(+32.1%)
$47.95 M(+1.3%)
Mar 2016
-
$47.33 M(+2.3%)
Dec 2015
-
$46.25 M(+6.4%)
Sep 2015
-
$43.46 M(+15.3%)
Jun 2015
$140.00 M(+6.5%)
$37.70 M(+15.4%)
Mar 2015
-
$32.67 M(-5.4%)
Dec 2014
-
$34.52 M(-1.7%)
Sep 2014
-
$35.11 M(+8.9%)
Jun 2014
$131.43 M(+21.1%)
$32.24 M(-27.2%)
Mar 2014
-
$44.32 M(+68.5%)
Dec 2013
-
$26.31 M(-7.9%)
Sep 2013
-
$28.55 M(+10.8%)
Jun 2013
$108.54 M(+21.1%)
$25.77 M(-2.1%)
Mar 2013
-
$26.31 M(-3.0%)
Dec 2012
-
$27.12 M(-7.6%)
Sep 2012
-
$29.34 M(+16.1%)
Jun 2012
$89.61 M(+12.7%)
$25.27 M(+15.1%)
Mar 2012
-
$21.95 M(+7.7%)
Dec 2011
-
$20.39 M(-7.3%)
Sep 2011
-
$22.00 M(-3.1%)
Jun 2011
$79.49 M(+22.0%)
$22.70 M(+11.7%)
Mar 2011
-
$20.31 M(+3.2%)
Dec 2010
-
$19.69 M(+17.3%)
Sep 2010
-
$16.79 M(-5.5%)
Jun 2010
$65.18 M(+9.0%)
$17.76 M(+14.3%)
Mar 2010
-
$15.54 M(-3.5%)
Dec 2009
-
$16.10 M(+2.0%)
Sep 2009
-
$15.78 M(+4.4%)
Jun 2009
$59.80 M(-19.6%)
$15.12 M(+18.7%)
Mar 2009
-
$12.74 M(-22.4%)
Dec 2008
-
$16.41 M(+5.6%)
Sep 2008
-
$15.54 M(-5.6%)
Jun 2008
$74.36 M(+30.8%)
$16.46 M(-41.1%)
Mar 2008
-
$27.96 M(+96.1%)
Dec 2007
-
$14.26 M(+7.6%)
Sep 2007
-
$13.26 M(-59.9%)
Jun 2007
$56.87 M
$33.08 M(+301.9%)
Mar 2007
-
$8.23 M(-42.6%)
DateAnnualQuarterly
Dec 2006
-
$14.33 M(+0.9%)
Sep 2006
-
$14.21 M(-5.4%)
Jun 2006
$50.81 M(+29.7%)
$15.02 M(+21.0%)
Mar 2006
-
$12.41 M(+11.9%)
Dec 2005
-
$11.09 M(-9.7%)
Sep 2005
-
$12.29 M(+32.3%)
Jun 2005
$39.16 M(+36.4%)
$9.29 M(-22.3%)
Mar 2005
-
$11.95 M(+38.7%)
Dec 2004
-
$8.61 M(-7.9%)
Sep 2004
-
$9.35 M(+23.7%)
Jun 2004
$28.71 M(-2.3%)
$7.56 M(-4.8%)
Mar 2004
-
$7.94 M(+20.2%)
Dec 2003
-
$6.61 M(+0.0%)
Sep 2003
-
$6.61 M(-16.1%)
Jun 2003
$29.39 M(+27.2%)
$7.87 M(+0.9%)
Mar 2003
-
$7.80 M(-0.8%)
Dec 2002
-
$7.86 M(+34.4%)
Sep 2002
-
$5.85 M(-8.4%)
Jun 2002
$23.10 M(+17.3%)
$6.39 M(-27.0%)
Mar 2002
-
$8.75 M(+105.5%)
Dec 2001
-
$4.26 M(+15.0%)
Sep 2001
-
$3.70 M(-27.8%)
Jun 2001
$19.70 M(+58.8%)
$5.13 M(-6.5%)
Mar 2001
-
$5.48 M(+17.5%)
Dec 2000
-
$4.67 M(+5.5%)
Sep 2000
-
$4.42 M(+4.0%)
Jun 2000
$12.40 M(+47.7%)
$4.25 M(+37.9%)
Mar 2000
-
$3.08 M(+18.6%)
Dec 1999
-
$2.60 M(+8.3%)
Sep 1999
-
$2.40 M(-4.0%)
Jun 1999
$8.40 M(-10.6%)
$2.50 M(+31.6%)
Mar 1999
-
$1.90 M(-5.0%)
Dec 1998
-
$2.00 M(+11.1%)
Sep 1998
-
$1.80 M(-37.9%)
Jun 1998
$9.40 M(-15.3%)
$2.90 M(+38.1%)
Mar 1998
-
$2.10 M(-8.7%)
Dec 1997
-
$2.30 M(0.0%)
Sep 1997
-
$2.30 M(-11.5%)
Jun 1997
$11.10 M(-36.2%)
$2.60 M(-3.7%)
Mar 1997
-
$2.70 M(-6.9%)
Dec 1996
-
$2.90 M(+7.4%)
Sep 1996
-
$2.70 M(-56.5%)
Jun 1996
$17.40 M(+171.9%)
$6.20 M(+106.7%)
Mar 1996
-
$3.00 M(-25.0%)
Dec 1995
-
$4.00 M(-4.8%)
Sep 1995
-
$4.20 M(-135.0%)
Jun 1995
$6.40 M(-1.5%)
-$12.00 M(-335.3%)
Mar 1995
-
$5.10 M(+183.3%)
Sep 1994
-
$1.80 M(-10.0%)
Jun 1994
$6.50 M(-70.3%)
$2.00 M(+33.3%)
Mar 1994
-
$1.50 M(-78.3%)
Dec 1993
-
$6.90 M(+430.8%)
Sep 1993
-
$1.30 M(-93.0%)
Jun 1993
$21.90 M(+13.5%)
$18.70 M(+2237.5%)
Mar 1993
-
$800.00 K(-11.1%)
Dec 1992
-
$900.00 K(-79.1%)
Sep 1992
-
$4.30 M(-20.4%)
Jun 1992
$19.30 M(+672.0%)
$5.40 M(+3.8%)
Mar 1992
-
$5.20 M(+642.9%)
Sep 1991
-
$700.00 K(0.0%)
Jun 1991
$2.50 M(+19.0%)
$700.00 K(+16.7%)
Mar 1991
-
$600.00 K(0.0%)
Dec 1990
-
$600.00 K(0.0%)
Sep 1990
-
$600.00 K(-14.3%)
Jun 1990
$2.10 M(+61.5%)
$700.00 K(+40.0%)
Mar 1990
-
$500.00 K(+25.0%)
Sep 1989
-
$400.00 K
Jun 1989
$1.30 M
-

FAQ

  • What is ImmunoGen annual total operating expenses?
  • What is the all time high annual operating expenses for ImmunoGen?
  • What is ImmunoGen annual operating expenses year-on-year change?
  • What is ImmunoGen quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for ImmunoGen?
  • What is ImmunoGen quarterly operating expenses year-on-year change?

What is ImmunoGen annual total operating expenses?

The current annual operating expenses of IMGN is $329.50 M

What is the all time high annual operating expenses for ImmunoGen?

ImmunoGen all-time high annual total operating expenses is $329.50 M

What is ImmunoGen annual operating expenses year-on-year change?

Over the past year, IMGN annual total operating expenses has changed by +$134.57 M (+69.04%)

What is ImmunoGen quarterly total operating expenses?

The current quarterly operating expenses of IMGN is $85.31 M

What is the all time high quarterly operating expenses for ImmunoGen?

ImmunoGen all-time high quarterly total operating expenses is $100.55 M

What is ImmunoGen quarterly operating expenses year-on-year change?

Over the past year, IMGN quarterly total operating expenses has changed by -$7.49 M (-8.07%)